USRE36268E
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and apparatus for amperometric diagnostic analysis
Assignee: Roche Diabetes Care Inc
•
Filing: 1996-07-12
•
Granted: 1999-08-17
•
Expires: 2016-07-12
Abstract
Abstract The present invention relates to a novel method and apparatus for the amperometric determination of an analyte, and in particular, to an apparatus for amperometric analysis utilizing a novel disposable electroanalytical cell for the quantitative determination of biologically important compounds from body fluids.
Inventors
- 👤 Neil J. Szuminsky
- 👤 Joseph Jordan, deceased
- 👤 Paul A. Pottgen
- 👤 Jonathan L. Talbott
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-06 18:41
CPC Classifications
C; C12; C12Q; C12Q1/00; C12Q1/001; C12Q1/004
Claims Analysis
Total Claims: 17
Claim 1
Independent Claim
100 words
A method of measuring the amount of a selected compound in body fluids comprising, a) providing a measuring cell having at least a first and second electrode and said cell containing an oxidant and a buffer, b) placing a sample of fluid to be tested in said cell, c) reconstituting said oxidant and buffer with said sample fluid to generate a predetermined reaction, d) allowing said reaction to proceed substantially to completion, e) applying a potential across said electrodes and sample, and f) measuring the resulting Cottrell current to determine the concentration of said selected compound present in said sample.
Claim 2
Independent Claim
100 words
A method of measuring the amount of a selected compound in body fluids comprising, a) providing a measuring cell having at least a first and second electrode and said cell containing an oxidant and a buffer, b) placing a sample of fluid to be tested in said cell, c) reconstituting said oxidant and buffer with said sample fluid to generate a predetermined reaction, d) allowing said reaction to proceed substantially to completion, e) applying a potential across said electrodes and sample, and f) measuring the resulting Cottrell current to determine the concentration of said selected compound present in said sample.
Claim 3
Dependent Claim
28 words
A method as set forth in claim 1, wherein the compound is selected from the group consisting of glucose, cholesterol, TSH, T4, hormones, antiarrhythmics, antiepileptics and nontherapeutic drugs.
Claim 4
Dependent Claim
28 words
A method as set forth in claim 1, wherein the oxidant is a material selected from the group consisting of benzoquinone, ferricyanide, ferricinium, .Iadd.orthophenanthroline .Iaddend.and Cobalt (III) dipyridyl.
Claim 5
Dependent Claim
25 words
The method as set forth in claim 1 including providing as said first electrode a working electrode and as said second electrode a reference electrode.
Claim 6
Dependent Claim
24 words
The method of claim 1 including also providing in said cell . .and.!. .Iadd.an .Iaddend.enzyme as a catalyst and said enzyme is an oxidoreductase.
Claim 7
Dependent Claim
124 words
The method of claim 1 including selecting said buffer from the group consisting of phosphate, TRIS, MOPS, MES, HEPES, Tricine, Bicine, ACES, CAPS and TAPS. . .7. A method for measuring the amount of glucose in blood, comprising a) providing a measuring cell having at least a first and second electrode and said cell containing an oxidant, a buffer and an enzyme, b) placing a blood sample to be tested in said cell, c) reconstituting said oxidant, buffer and enzyme with said blood sample to generate a predetermined reaction, d) essentially immediately applying a potential across said electrodes and blood sample, and e) measuring the resultant Cottrell current when the reaction has proceeded to completion to determine the concentration of said glucose present in
Claim 8
Dependent Claim
60 words
blood sample..!.. .8. The method of claim 7 including selecting said oxidant from the group consisting of benzoquinone, ferricyanide, ferricinium, Cobalt (III) orthophenantroline, and Cobalt (III) dipyridyl..!.. .9. The method of claim 7 including providing as said first electrode a working electrode and said second electrode a reference electrode..!.. .10. The method of claim 7 including adding as said enzyme,
Claim 9
Dependent Claim
182 words
glucose oxydase..!.11. The method of claim 1 wherein .Iadd.the sample of fluid is blood and .Iaddend.in step b) said placing of the blood sample to be tested in the cell generates a current and initiates a timing sequence, and wherein the reaction of step d) is allowed to proceed with an open circuit between said first and second . .electrode.!. .Iadd.electrodes.Iaddend.. .Iadd.12. A method of measuring the amount of an analyte in a blood sample, comprising: a) adding the blood sample to an electrochemical cell that includes an electron transfer agent that will react in a reaction involving the analyte, thereby forming a detectable species; b) incubating the reaction involving analyte and electron transfer agent in an open circuit until the reaction has substantially completed; c) applying a sufficient potential difference between the electrodes of the electrochemical cell, after the incubation step, to readily transfer at least one electron between the detectable species and one of the electrodes, thereby resulting in a Cottrell current; d) measuring the Cottrell current; and e) correlating the measured Cottrell current to the amount of analyte in
Claim 10
Dependent Claim
284 words
the blood sample..Iaddend..Iadd.13. The method of claim 12, wherein adding the blood sample to the electrochemical cell causes a sudden charging current, which automatically initiates incubation step b) performed under open circuit..Iaddend..Iadd.14. The method of claim 13, wherein the Cottrell current is measured at a preset time following the incubation step..Iaddend..Iadd.15. The method of claim 12, wherein the electrochemical cell further includes a catalyst in sufficient amount to catalyze the reaction involving the analyte and the electron transfer agent..Iaddend..Iadd.16. The method of claim 15, wherein the catalyst is an enzyme..Iaddend..Iadd.17. The method of claim 16, wherein the analyte is glucose and the enzyme is glucose oxidase..Iaddend..Iadd.18. The method of claim 12, wherein the electron transfer agent is included in a reagent layer that is coated directly onto the electrochemical cell or is incorporated into a supporting matrix that is placed into the electrochemical cell..Iaddend..Iadd.19. The method of claim 18, wherein the supporting matrix is filter paper, membrane filter, woven fabric, or nonwoven fabric..Iaddend..Iadd.20. The method of claim 18, wherein the reagent layer further includes a binder..Iaddend..Iadd.21. The method of claim 20, wherein the binder is gelatin, carrageenan, methylcellulose, polyvinyl alcohol, or polyvinylpyrrolidone..Iaddend..Iadd.22. The method of claim 21, wherein a dispersing, spreading, or wicking layer overlays the reagent layer..Iaddend..Iadd.23. The method of claim 18, wherein adding the blood sample to the electrochemical cell causes a sudden charging current, which automatically initiates incubation step b) performed under open circuit..Iaddend..Iadd.24. The method of claim 23, wherein the Cottrell current is measured at a preset time following the incubation step..Iaddend..Iadd.25. The method of claim 24, wherein the reagent layer further includes an enzyme catalyst in sufficient amount to catalyze the reaction involving the analyte and the electron transfer
Claim 11
Dependent Claim
301 words
agent..Iaddend..Iadd.26. The method of claim 25, wherein the analyte is glucose in a concentration from about 1 milligram glucose per deciliter of blood sample to about 1000 milligrams glucose per deciliter of blood sample, and the fluid sample is blood..Iaddend..Iadd.27. The method of claim 26, wherein the electron transfer agent is ferricyanide, ferricinium, cobalt (III) orthophenanthroline, cobalt (III) dipyridyl, or benzoquinone..Iaddend..Iadd.28. The method of claim 12, wherein the analyte is glucose, TSH, T 4 , a hormone, a cardiac glycoside, an antiarrhythmic, an antiepileptic, an antibiotic, cholesterol, or a non-therapeutic drug..Iaddend..Iadd.29. The method of claim 25, wherein the analyte is glucose in a concentration from about 1 milligram glucose per deciliter of blood sample to about 1000 milligrams glucose per deciliter of blood sample, the incubation period is from about 15 seconds to about 160 seconds, and current measurements are made in the range from about 2 seconds to about 30 seconds following the incubation step..Iaddend..Iadd.30. A method of measuring the amount of an analyte in a blood sample, comprising: a) adding the blood sample to an electrochemical cell that includes an electron transfer agent, a first catalyst in sufficient amount to catalyze a first reaction involving the analyte, and a second catalyst in sufficient amount to catalyze a second reaction involving a product of the first reaction and the electron transfer agent, thereby forming a detectable species; b) incubating the first and second reactions in an open circuit until the reactions have substantially completed; c) applying a sufficient potential difference between electrodes of the electrochemical cell, after the incubation step, to readily transfer at least one electron between the detectable species and one of the electrodes, thereby resulting in a Cottrell current; d) measuring the Cottrell current; and e) correlating the measured Cottrell current to the amount of analyte in
Claim 12
Dependent Claim
256 words
the blood sample..Iaddend..Iadd.31. The method of claim 30, wherein adding the blood sample to the electrochemical cell causes a sudden charging current, which automatically initiates incubation step b) performed under open circuit..Iaddend..Iadd.32. The method of claim 31, wherein the Cottrell current is measured at a preset time following the incubation step..Iaddend..Iadd.33. A method of measuring the amount of cholesterol in a blood sample, comprising: a) adding the blood sample to an electrochemical cell that includes an electron transfer agent, cholesterol esterase in sufficient amount to catalyze the hydrolysis of cholesterol esters in the blood sample, thereby forming cholesterol, cholesterol oxidase in sufficient amount to catalyze a reaction involving cholesterol and the electron transfer agent, thereby forming a detectable species; b) incubating the reactions of step a) in an open circuit until those reactions have substantially completed; c) applying a sufficient potential difference between electrodes of the electrochemical cell, after the incubation step, to readily transfer at least one electron between the detectable species and one of the electrodes, thereby resulting in a Cottrell current; d) measuring the Cottrell current; and e) correlating the measured Cottrell current to the amount of cholesterol in the blood sample..Iaddend..Iadd.34. The method of claim 33, wherein adding the blood sample to the electrochemical cell causes a sudden charging current, which automatically initiates incubation step b) performed under open circuit..Iaddend..Iadd.35. The method of claim 34, wherein the Cottrell current is measured at a preset time following the incubation step..Iaddend..Iadd.36. The method of claim 35, wherein the electron transfer agent is ferricyanide or
Claim 13
Dependent Claim
321 words
benzoquinone..Iaddend..Iadd. A method of measuring the amount of an analyte in a blood sample, comprising: a) adding the blood sample to an electrochemical cell that includes first and second electron transfer agents, a first catalyst in sufficient amount to catalyze a first reaction involving the analyte, a second catalyst in sufficient amount to catalyze a second reaction involving a product of the first reaction and the first electron transfer agent, thereby forming an intermediate species that reacts with the second electron transfer agent, thereby forming a detectable species; b) incubating the reactions of step a) in an open circuit until those reactions have substantially completed; c) applying a sufficient potential difference between electrodes of the electrochemical cell, after the incubation step, to readily transfer at least one electron between the detectable species and one of the electrodes, thereby resulting in a Cottrell current; d) measuring the Cottrell current; and e) correlating the measured Cottrell current to the amount of analyte in the blood sample..Iaddend..Iadd.38. A method of measuring the amount of cholesterol in a blood sample, comprising: a) adding the blood sample to an electrochemical cell that includes first and second electron transfer agents, cholesterol esterase in sufficient amount to catalyze the hydrolysis of cholesterol esters in the blood sample, thereby forming cholesterol, cholesterol oxidase in sufficient amount to catalyze a reaction involving cholesterol and the first electron transfer agent, thereby forming an intermediate species that reacts with the second electron transfer agent, thereby forming a detectable species; b) incubating the reactions of step a) in an open circuit until those reactions have substantially completed; c) applying a sufficient potential difference between the electrodes of the electrochemical cell, after the incubation step, to readily transfer at least one electron between the detectable species and one of the electrodes, thereby resulting in a Cottrell current; d) measuring the Cottrell current; and e) correlating the measured Cottrell current to the amount of cholesterol
Claim 14
Dependent Claim
321 words
benzoquinone..Iaddend..Iadd. A method of measuring the amount of an analyte in a blood sample, comprising: a) adding the blood sample to an electrochemical cell that includes first and second electron transfer agents, a first catalyst in sufficient amount to catalyze a first reaction involving the analyte, a second catalyst in sufficient amount to catalyze a second reaction involving a product of the first reaction and the first electron transfer agent, thereby forming an intermediate species that reacts with the second electron transfer agent, thereby forming a detectable species; b) incubating the reactions of step a) in an open circuit until those reactions have substantially completed; c) applying a sufficient potential difference between electrodes of the electrochemical cell, after the incubation step, to readily transfer at least one electron between the detectable species and one of the electrodes, thereby resulting in a Cottrell current; d) measuring the Cottrell current; and e) correlating the measured Cottrell current to the amount of analyte in the blood sample..Iaddend..Iadd.38. A method of measuring the amount of cholesterol in a blood sample, comprising: a) adding the blood sample to an electrochemical cell that includes first and second electron transfer agents, cholesterol esterase in sufficient amount to catalyze the hydrolysis of cholesterol esters in the blood sample, thereby forming cholesterol, cholesterol oxidase in sufficient amount to catalyze a reaction involving cholesterol and the first electron transfer agent, thereby forming an intermediate species that reacts with the second electron transfer agent, thereby forming a detectable species; b) incubating the reactions of step a) in an open circuit until those reactions have substantially completed; c) applying a sufficient potential difference between the electrodes of the electrochemical cell, after the incubation step, to readily transfer at least one electron between the detectable species and one of the electrodes, thereby resulting in a Cottrell current; d) measuring the Cottrell current; and e) correlating the measured Cottrell current to the amount of cholesterol
Claim 15
Dependent Claim
99 words
in the blood sample..Iaddend..Iadd.39. The method of claim 38, wherein adding the blood sample to the electrochemical cell causes a sudden charging current, which automatically initiates incubation step b) performed under open circuit..Iaddend..Iadd.40. The method of claim 39, wherein the Cottrell current is measured at a preset time following the incubation step..Iaddend..Iadd.41. The method of claim 40, wherein the first electron transfer agent is benzoquinone, phenazine ethosulfate, phenazine methosulfate, tetramethylbenzidine, a derivative of benzoquinone, naphthoquinone, a derivative of naphthoquinone, anthraquinone, a derivative of anthraquinone, catechol, phenylenediamine, tetramethylphenylenediamine, or a derivative of phenylenediamine..Iaddend..Iadd.42. The method of claim 41, wherein the
Claim 16
Dependent Claim
264 words
second electron transfer agent is ferricyanide..Iaddend..Iadd.43. A method for measuring the amount of a selected compound in a blood sample, comprising: providing a measuring cell having at least first and second electrodes for contact with the blood sample introduced into the cell, applying a potential to the electrodes to detect the presence of the blood sample in the cell, placing the blood sample into the cell, removing the potential to the electrodes after the blood sample is detected in the cell, selectively oxidizing the compound in the blood sample with an oxidized electron acceptor to produce an oxidized form of the selected compound and a reduced electron acceptor, and re-applying a potential across the cell electrodes after the selective oxidation of the compound in the blood sample has substantially completed and measuring the resulting Cottrell current, said current being proportional to the concentration of the reduced electron acceptor and the selected compound in the blood sample..Iaddend..Iadd.44. The method of claim 43, wherein placing the fluid sample into the measuring cell causes a sudden charging current, which automatically initiates removal of the potential from the electrodes and performance of the selective oxidation of the selected compound under open circuit..Iaddend..Iadd.45. The method of claim 44, wherein the Cottrell current is measured at the preset time after re-application of a potential across the measuring cell electrodes..Iaddend..Iadd.46. The method of claim 47, wherein placing the volume of blood into the measuring cell causes a sudden charging current, which automatically initiates removal of the potential across the electrodes and performance of the oxidation of glucose in the blood under
Claim 17
Dependent Claim
150 words
open circuit..Iaddend..Iadd.47. A method for measuring the amount of glucose in blood, comprising: providing a measuring cell with at least first and second electrodes for contact with blood introduced into the cell, applying a potential across the electrodes, placing a volume of blood into the cell, removing the potential across the electrodes after the volume of blood is placed into the measuring cell, oxidizing the glucose in the blood with an oxidized electron acceptor in the presence of glucose oxidase to produce gluconic acid and a reduced electron acceptor, re-applying a potential across the measuring cell electrodes after the oxidation of glucose has substantially completed, and measuring the Cottrell current through the cell, the Cottrell current being proportional to the glucose concentration in the blood..Iaddend..Iadd.48. The method of claim 46, wherein the Cottrell current is measured at a preset time after re-application of a potential across the measuring cell electrodes..Iaddend.
References Cited (Backward Citations)
US3838033A
Cited
US3925183A
Cited
US4005002A
Cited
US4224125A
Cited
US4321123A
Cited
US4217196A
Cited
JPS5510584A
Cited
US4392933A
Cited
US4225410A
Cited
US4169779A
Cited
US4407959A
Cited
US4420564A
Cited
JPS5798853A
Cited
US4431507A
Cited
US4682602A
Cited
US4545382A
Cited
JPS59166852A
Cited
EP0136362A1
Cited
US4711245A
Cited
US4758323A
Cited
US4655901A
Cited
US4654197A
Cited
US4579643A
Cited
GB2154003A
Cited
JPS60173459A
Cited
JPS60173457A
Cited
JPS60173458A
Cited
JPS60211350A
Cited
US4810633A
Cited
US5141868A
Cited
EP0170375B1
Cited
US4820399A
Cited
EP0177743B1
Cited
JPS6190050A
Cited
JPS6191558A
Cited
US4948727A
Cited
US5171689A
Cited
US4820636A
Cited
WO1986004926A1
Cited
US4836904A
Cited
EP0230472A1
Cited
US4897173A
Cited
WO1986007632A1
Cited
JPS61294356A
Cited
US4938860A
Cited
US5030310A
Cited
EP0206218A2
Cited
US5140393A
Cited
US4830959A
Cited
US4935106A
Cited
EP0230786A1
Cited
JPS62156553A
Cited
EP0241309A2
Cited
US4970145A
Cited
US4959305A
Cited
JPS633249A
Cited
US4927516A
Cited
EP0255291A1
Cited
US5049487A
Cited
JPS6358149A
Cited
US4894137A
Cited
JPS63128252A
Cited
US4935105A
Cited
US4952300A
Cited
US4796014A
Cited
US4995402A
Cited
EP0785901A1
Cited
EP0786361A1
Cited
EP1251371A1
Cited
EP1363621A1
Cited
EP1279581A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2002-08-16 | 2003-02-15 | 2003-08-17 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2006-08-16 | 2007-02-15 | 2007-08-17 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2010-08-16 | 2011-02-15 | 2011-08-17 | $7700.00 | Window Closed / Lapsed |